ICML 2025: Regimens for Patients With High-Risk CLL
Update: 2025-09-30
Share
Description
Drs. Seshadri and Fahkri review abstracts exploring treatments for patients with high-risk CLL, including SEQUOIA Arm C and CLL16 studies.
Comments
In Channel



